Skip to main content

53 publications

Name Date Type Actions

Buyback programs - december 2022 Monthly communication regarding buyback programs

04/01/2023 Description of buyback programs

Monthly information regarding the total number of voting rights - december 2022

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

05/01/2023 Voting rights

2023 calendar of financial communication

Vetoquinol published its calendar of financial communication for 2023.

10/01/2023 Agenda

CALENDAR 2023 Stock exchange market – non authorized periods

The "negative windows" are the abstention periods during which it is forbidden to trade in the Company's securities.

13/01/2023 Financial Documents

Annual sales 2022

Total group Sales: €540 million (up 3.6% as reported)
Annual Sales of Essential products: €304 million (up 4.5% as reported)

18/01/2023 Public releases

In 2023 Vetoquinol celebrates its 90th anniversary. - 90 years

The story of an incredible family saga. From a regional pharmaceutical laboratory to a world leader in animal health.

31/01/2023 Press releases communication

Buyback programs - January 2023

Monthly communication regarding buyback programs 

07/02/2023 Description of buyback programs

Monthly information regarding the total number of voting rights - January 2023

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the «Reglement Général de L’Autorité des Marchés Financiers »

07/02/2023 Voting rights

Buyback programs - February 2023

Monthly communication regarding buyback programs

06/03/2023 Description of buyback programs

Monthly information regarding the total number of voting rights - February 2023

As per articles L233‐8‐II of « Code de Commerce » and  223.16 of the « Reglement Général de L’Autorité des Marchés Financiers »

06/03/2023 Voting rights